Evidence map›Paper›PMID 32107448›Full record

ArticleScientific reports2020

Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells.

Renuka M Chaphalkar, Dorota L Stankowska, Shaoqing He, Bindu Kodati, Nicole Phillips, Jude Prah, Shaohua Yang, Raghu R Krishnamoorthy

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Oral administration of a dual ETMolecular vision · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Renuka M ChaphalkarNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Dorota L StankowskaNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Shaoqing HeNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Bindu KodatiNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Nicole PhillipsDepartment of Microbiology, Immunology and Genetics, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Jude PrahDepartment of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, 19104, United States.
Shaohua YangNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States.
Raghu R KrishnamoorthyNorth Texas Eye Research Institute, Department of Pharmacology and Neuroscience, UNT Health Science Center, Fort Worth, Texas, 76107, United States. raghu.krishnamoorthy@unthsc.edu.
University of North Texas Health Science Center · USUniversity of North Texas · USSmith-Kettlewell Eye Research Institute · USUniversity of Pennsylvania · US

Funding

Mechanisms underlying endothelin mediated neurodegeneration in glaucomaR01EY028179 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KRISHNAMOORTHY, RAGHU R · 2017 to 2025
$2.9M
NEI NIH HHS R01 EY028179
6 · The paper itself

Abstract

Endothelin-1 (ET-1) is a vasoactive peptide that is elevated in aqueous humor as well as circulation of primary open angle glaucoma (POAG) patients. ET-1 has been shown to promote degeneration of optic nerve axons and apoptosis of retinal ganglion cells (RGCs), however, the precise mechanisms are still largely unknown. In this study, RNA-seq analysis was used to assess changes in ET-1 mediated gene expression in primary RGCs, which revealed that 23 out of 156 differentially expressed genes (DEGs) had known or predicted mitochondrial function, of which oxidative phosphorylation emerged as the top-most enriched pathway. ET-1 treatment significantly decreased protein expression of key mitochondrial genes including cytochrome C oxidase copper chaperone (COX17) and ATP Synthase, H

Indexed as

AnimalsCopper Transport ProteinsDisease Models, AnimalEndothelin-1Energy MetabolismFemaleGene ExpressionGlaucomaHumansMaleMitochondriaMitochondrial Proton-Translocating ATPasesNerve DegenerationRatsRats, Inbred BNRetinal Ganglion CellsCopper Transport ProteinsCox17 protein, ratEndothelin-1Mitochondrial Proton-Translocating ATPases

Identifiers

PMID32107448
PMCPMC7046667
OpenAlexW3010417908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.